A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis

Masahide Yazaki, John Varga, P. James B. Dyck, Merrill D. Benson

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


We report a 40-year-old woman with a new transthyretin (TTR) variant, glutamine replacing leucine at residue 55 (Leu55Gln), who showed progressive somatic and autonomic neuropathy, glaucoma, and vitreous opacities. Symptoms of glaucoma appeared prior to the onset of the neuropathy. Sural nerve biopsy revealed amyloid deposition in the endoneurium, and immunohistochemical analysis was positive with anti-human TTR. Sequencing of the patient's DNA revealed the substitution of A for T at the second position of codon 55 of the TTR gene indicating an amino acid change from leucine to glutamine.

Original languageEnglish (US)
Pages (from-to)268-271
Number of pages4
Issue number4
StatePublished - Dec 2002


  • Amyloidosis
  • Glaucoma
  • Polyneuropathy
  • Transthyretin

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis'. Together they form a unique fingerprint.

Cite this